Kalion is scaling up synthetic biological pathways, using traditional

fermentation technology, to produce higher concentrations (titers) of two

key chemical intermediates -- glucaric acid and 3-HBL -- for

commercialization via licenses and/or other business relationships with

industrial partners.

Contact Us Today!

To find out more about our investment criteria and what we're looking for, please send us an email .



Articles & Updates

SEC Rules and the Startup World - The Latest

The world of equity fundraising has really changed since September 23, when the SEC rules lifting the ban on general solicitation became effective.

Read more

Print | Sitemap
© Home Run Ventures